Lilly's baricitinib shows hair regrowth in adolescents with alopecia areata
Tweet Send to a Friend
Eli Lilly and Company (NYSE: LLY) reported that 54.1% of adolescents with severe alopecia areata achieved successful hair regrowth after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
